#Taiwan #Medical Devices #Hsinchu #ICP DAS-BMP #TPU Materials

ICP DAS-BMP Participates in MOU Signing Ceremony

On October 28, 2025, ICP DAS-BMP took part in a pivotal signing ceremony for a Strategic Memorandum of Understanding (MOU) hosted by Towards Buddha Co., Ltd. This event not only showcased the company’s advancements and applications in medical-grade thermoplastic polyurethane (TPU) materials but also marked a significant step towards collaboration and innovation in the medical supply chain.

The signing ceremony assembled a consortium of industry professionals, including esteemed partners such as Intype Enterprise Co., Ltd., A-Max Technology Co., Ltd., and MedServ Biotech Co., Ltd. The collaboration aims to merge diverse expertise across various sectors—from TPU material manufacturing to precision engineering in medical devices.

Advancements in Medical-Grade TPU Materials

ICP DAS-BMP presented its extensive research and development accomplishments, spotlighting its commitment to enhancing the quality and applicability of TPU materials within the medical field. Their offerings include a comprehensive range of TPU materials that are wholly suitable for diverse medical applications like catheters, guidewire coatings, and Luer-Lock connectors.

Among the products showcased, the Arothane™, Alithane™, and Durathane™ TPUs from the ARP/ALP/ALC series fulfill the stringent requirements for body-contact medical devices. Notably, the Arothane™ ARP-B20 and Durathane™ ALC-B40 have successfully passed the ISO 10993-6 implantation test for 13 weeks, paving the way for implantation procedures lasting up to 90 days. These materials exhibit exceptional biocompatibility and dispersibility, making them ideal candidates for use in invasive catheter manufacturing.

Commitment to Innovation and Partnership

The strategic MOU sets the groundwork for ICP DAS-BMP to work closely with industry experts and think tanks to foster innovation and enhance the global presence of TPU materials in the healthcare sector. The company’s goal is to solidify its competitive edge in the medical supply chain while supporting partners in creating comprehensive, reliable medical devices.

With a strong focus on safety and exceptional quality, ICP DAS-BMP ensures continued collaboration with existing customers and partners established through the MOU. The firm is determined to drive forward the development of TPU materials that meet the evolving needs of medical applications worldwide.

About ICP DAS-BMP

Based in Taiwan, ICP DAS-BMP stands as a leading manufacturer and provider of TPU materials, certified under ISO 13485. The company leverages over three decades of experience in industrial automation to enhance product quality and ensure prompt delivery. By employing cutting-edge smart factory practices, ICP DAS-BMP offers responsive post-sales support and adaptable solutions, accommodating even small production quantities. The firm believes in nurturing long-term partnerships that prioritize customer satisfaction.

For more details on ICP DAS-BMP and its range of medical-grade TPU materials, visit their official website.

In conclusion, ICP DAS-BMP's participation in the MOU signing represents a significant turning point for the use of TPU materials in the healthcare sector. Through strategic partnerships and a commitment to quality, the future looks promising for advancements in medical device manufacturing.